CN108836912B - Blue-light-resistant and infrared-resistant composition and application thereof - Google Patents

Blue-light-resistant and infrared-resistant composition and application thereof Download PDF

Info

Publication number
CN108836912B
CN108836912B CN201810987092.5A CN201810987092A CN108836912B CN 108836912 B CN108836912 B CN 108836912B CN 201810987092 A CN201810987092 A CN 201810987092A CN 108836912 B CN108836912 B CN 108836912B
Authority
CN
China
Prior art keywords
composition
stirring
temperature
dimethicone
cooling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810987092.5A
Other languages
Chinese (zh)
Other versions
CN108836912A (en
Inventor
朱光群
何淋
刘显曜
刘逸华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Cosmetics China Co ltd
Original Assignee
Global Cosmetics China Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Cosmetics China Co ltd filed Critical Global Cosmetics China Co ltd
Priority to CN201810987092.5A priority Critical patent/CN108836912B/en
Publication of CN108836912A publication Critical patent/CN108836912A/en
Application granted granted Critical
Publication of CN108836912B publication Critical patent/CN108836912B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The invention provides a blue light-resistant and infrared-proof composition and application thereof, wherein the composition comprises 1-5 parts by weight of Shield MLDA (coffee Arabic seed extract) and 0.5-4 parts by weight of

Description

Blue-light-resistant and infrared-resistant composition and application thereof
Technical Field
The invention relates to the field of cosmetics, and mainly relates to a blue light-resistant and infrared-resistant composition and application thereof.
Background
Blue light, one of the urban light pollutions, has become two major light pollutions which affect the skin most with ultraviolet light. Our daily use of computers produces blue light, with 8 hours of blue light exposure corresponding to 1 hour of sun exposure.
The blue light is a light existing all the time in the nature and also an important component of sunlight, and with the development of scientific technology, the blue light has increasingly serious harm to the skin and eyes of people in light sources such as mobile phones, computers, projectors, LED table lamps, automobile headlights and the like which are in daily contact with people. High energy short wave blue light can cause eye diseases of different degrees, such as asthenopia, visual deterioration, cataract, AMD, and even blindness. High-energy short-wave blue light at night can inhibit melatonin secretion, so that biological clock disorder is caused, and various diseases of the body are caused. The long-term exposure of the human body to blue light not only causes visual fatigue and premature eye failure, but also generates oxidative stress and increases skin photodamage. If permanently exposed to electronic devices such as cell phones, tablets and computers, fluorescent bulbs and LED light sources just before sleep, sleep disorders, melatonin malfunction and premature eye failure will result. Just as with uv protection, it is also necessary to protect the skin from the hazards of blue light, which can help alleviate premature aging of the skin. In addition, the damage of infrared rays to the skin is not paid enough attention, the penetrating power of heat radiation caused by the infrared rays to the skin is stronger than that of ultraviolet rays, the damage of the ultraviolet rays can be enhanced, and when the skin is irradiated by the ultraviolet rays and the infrared rays, erythema is more easily generated, and water in the skin is correspondingly lost.
In addition, as the climate becomes warm and the ozone layer is destroyed, the exposure opportunities of visible blue light (400-. In the technical specification for cosmetic safety (2015 edition), 27 standard sunscreens are specified, wherein 25 organic sunscreens and 2 inorganic sunscreens are provided, but the organic sunscreens and the inorganic sunscreens are artificially synthesized chemical sunscreen structures, and the ingredients can only protect ultraviolet rays in a UVB band and a UVA band generally and do not relate to protection of a near infrared band and a visible blue band. When a wider band of protection is required, especially near infrared and blue bands, only the 27 sunscreens prescribed by the state are not sufficient. CN105434188A provides a sunscreen cream and a preparation method thereof, wherein the sunscreen cream comprises the following components: physical sunscreen agents, based on the total weight of the sunscreen cream: 2 to 10 percent; preferably 5 to 10%; chemical sunscreen agents: 2 to 30 percent; preferably 15 to 25%; antioxidant: 0.01-1%; preferably 0.1-0.8%; grease: 5.5 to 20 percent; preferably 10-20%; emulsifier: 2 to 6 percent; preferably 4 to 6%; humectant: 3 to 15 percent; preferably 8 to 15%; carnosine: 0.1-2%; preferably 0.1 to 1.5%; water: 10 to 85 percent; preferably 22-53%. The sunscreen cream provided by the invention can protect the harm of infrared rays to human tissues. However, the above prior art can only protect infrared rays and cannot resist the damage of blue light to the skin.
In conclusion, the composition capable of resisting blue light and infrared rays is provided and applied to cosmetics, and has wide application prospect and great market value for repairing and protecting the skin damaged by light.
Disclosure of Invention
In order to solve the defects of the prior art and the market demand, the invention provides a composition and application thereof, in particular to a composition for resisting blue light and preventing red addition and application thereof.
In order to achieve the above objects, in a first aspect, the present invention provides a blue light-resistant and infrared-resistant composition comprising 1 to 5 parts by weight of Shield MLDA and 0.5 to 4 parts by weight of carnosine.
The Shield MLDA is extracted from Arab coffee seeds, and the carnosine is
Figure BDA0001779950840000031
PLUS。
Shield MLDA, a natural active substance extracted from Brazilian coffee, is also melatonin and blue light protection extract, is a pure natural filtering component obtained from roasted Arabica coffee biomass through a subcritical extraction method, contains melanoidin mixture and rich chlorogenic acid generated in the roasting process of coffee, has the characteristics of oxidation resistance and aging resistance, has the effects of absorbing ultraviolet rays and resisting blue light, is added into a product, and can effectively prevent the influence of the ultraviolet rays and the blue light on skin blackening and aging
Figure BDA0001779950840000032
PLUS (carnosine), IRA induces a large production of free radicals by mitochondria and up-regulates MMP, that is IRA induces an increase in MMP production, MMP production is reduced by increased collagen consumption,
Figure BDA0001779950840000033
the raw material PLUS, wherein the inhibitor can bind IRA and not induce MMP, thereby achieving the effects of infrared resistance, inflammation inhibition and the like.
In the invention, through the intensive research on raw materials for sunscreen repair and light damage resistance, the inventor summarizes the advantages and the disadvantages of various products in the prior art, screens and matches the raw materials from thousands of candidate materials, discovers a novel active component Shield MLDA from the past meetings and papers, and on the basis of the discovery, combines the Shield MLDA with the active component Shield MLDA
Figure BDA0001779950840000034
The PLUS (carnosine) is reasonably compounded, the matching proportion is optimized, the blue light-resistant and infrared-resistant composition is obtained, and the two compositions play an excellent protection function and a synergistic interaction effect under the matching of a specific proportion, so that the blue light-resistant and infrared-resistant composition mutually makes good use of the advantages and disadvantages in the aspect of absorbing blue light and infrared rays, and has an obvious effect.
Preferably, the parts by weight of Shield MLDA may be, for example, 1 part, 2 parts, 3 parts, 4 parts, or 5 parts.
Preferably, the weight parts of carnosine may be, for example, 0.5 parts, 1 part, 2 parts, 3 parts or 4 parts.
Preferably, the composition comprises 2 to 4 parts of Shield MLDA and 1 to 3 parts of carnosine by weight.
In a second aspect, the present invention provides the use of a composition as described in the first aspect for the preparation of a cosmetic product.
In a third aspect, the present invention provides a cosmetic comprising the composition of the first aspect.
Preferably, the cosmetic comprises any one of or a combination of at least two of a lotion, a cream, an eye cream, a sunscreen cream or a liquid foundation, preferably a liquid foundation.
The general foundation liquid on the market has the effects of concealing, brightening skin, preventing sun and the like, but has no blue light and infrared ray resisting effects.
Preferably, the composition is added in an amount of 1.5 to 9% by mass, for example, 1.5%, 2%, 3%, 4%, 5%, 6%, 7% or 9%.
In a fourth aspect, the present invention provides a method for preparing a liquid foundation, comprising the following steps:
(1) adding the water phase components into a water phase pot, heating, stirring, dissolving, keeping the temperature for 30 minutes, and cooling to 30-38 ℃ for later use;
(2) adding the oil phase components into an emulsifying pot, stirring uniformly, heating, stirring, dissolving, keeping the temperature for 30 minutes, and cooling to 30-38 ℃ for later use;
(3) and (2) slowly pumping the water phase obtained in the step (1) into an emulsifying pot for homogenizing and emulsifying, adding the additive and the composition in the first aspect, and stirring and dispersing uniformly to obtain the foundation liquid.
Preferably, the aqueous phase of step (1) comprises: any one or combination of at least two of water, glycerin, butanediol, betaine, sodium chloride, methylparaben or disodium EDTA.
The amount of the aqueous phase added may be, for example, water (36.23%), glycerin (6.0%), butylene glycol (4.0%), betaine (2.0%), sodium chloride (1.0%), methylparaben (0.2%) and disodium EDTA (0.05%).
Preferably, the heating temperature in step (1) is 60-70 deg.C, such as 60 deg.C, 62 deg.C, 64 deg.C, 66 deg.C, 68 deg.C or 70 deg.C.
Preferably, the temperature for reducing the temperature in step (1) is 30-38 ℃, and may be, for example, 30 ℃, 32 ℃, 34 ℃, 36 ℃, 37 ℃ or 38 ℃.
Preferably, the oil phase of step (2) comprises: cyclopentadimethylsiloxane, CI 77891, butanediol dicaprylate/dicaprate, octyl methicone, dimethicone, lauryl PEG-9 dimethiconoethyl dimethicone, PEG-10 dimethicone, acrylate/dimethicone copolymer, methyl methacrylate crosspolymer, vinyl dimethicone/methicone silsesquioxane crosspolymer, magnesium stearate, aluminum hydroxide, triethoxyoctylsilane, cyclohexasiloxane, CI 77491, CI 77499, or CI 77492, or any one or combination of at least two thereof.
The amount of the oil phase may be, for example, cyclopentadimethylsiloxane (12.0%), CI 77891 (8.0%), butanediol dicaprylate/dicaprate (5.0%), octyl methicone (3.0%), dimethicone (1.5%), lauryl PEG-9 dimethiconoethyl dimethicone (2.0%), PEG-10 dimethicone (2.5%), acrylate/dimethicone copolymer (5.0%), methyl methacrylate crosspolymer (2.0%), vinyl dimethicone/polymethylsiloxane silsesquioxane crosspolymer (1.0%), magnesium stearate (0.5%), aluminum hydroxide (0.01%), triethoxy octyl silane (0.05%), cyclohexasiloxane (0.1%), CI 77491 (0.8%), CI 77499 (0.3%), and CI 77492 (0.06%).
Preferably, the temperature of the incubation in step (2) is 30-38 deg.C, and may be, for example, 30 deg.C, 32 deg.C, 34 deg.C, 36 deg.C, 37 deg.C or 38 deg.C.
Preferably, the rotation speed for homogenizing in step (3) is 2000-2800 rpm, such as 2000 rpm, 2100 rpm, 2200 rpm, 2300 rpm, 2400 rpm, 2500 rpm, 2600 rpm, 2700 rpm or 2800 rpm.
Preferably, the temperature of said temperature reduction in step (3) is 20-25 deg.C, such as 20 deg.C, 21 deg.C, 22 deg.C, 23 deg.C, 24 deg.C or 25 deg.C.
Preferably, the additive comprises any one or a combination of at least two of phenoxyethanol, ethylhexyl glycerol, tocopherol acetate, bisabolol, sodium hyaluronate or a perfume.
The additive may be, for example, phenoxyethanol (0.5%), ethylhexylglycerin (0.1%), tocopheryl acetate (0.5%), bisabolol (0.5%), sodium hyaluronate (0.05%) and perfume (0.05%).
In the invention, the inventor optimizes the parameter conditions of the composition in preparing the foundation fluid through researching the physicochemical properties of the composition, and finally ensures that the composition plays the best effect in the foundation fluid.
As a preferred technical scheme, the preparation method of the foundation liquid specifically comprises the following steps:
(1) adding the water phase components into a water phase pot, heating to 60-70 ℃, stirring for dissolving, keeping the temperature for 30 minutes, and cooling to 30-38 ℃ for later use;
(2) adding the oil phase components into an emulsifying pot, stirring uniformly, heating to 60-70 ℃, stirring for dissolving, keeping the temperature for 30 minutes, and cooling to 30-38 ℃ for later use;
(3) slowly pumping the water phase in the step (1) into an emulsifying pot for homogenizing and emulsifying at the rotation speed of 2000-2800 r/min, then adding the additive and the composition in the first aspect, stirring and cooling to 20-25 ℃ to obtain the liquid foundation.
Compared with the prior art, the invention has the following advantages:
the composition provided by the invention is based on Shield MLDA and is reasonably matched
Figure BDA0001779950840000061
PLUS, in a specific range, the two synergistically enhance and mutually promote, the absorption and resistance of the composition to blue light and infrared rays are enhanced, sensitive skin is repaired, the absorption degree to blue light reaches 2.9, the absorption degree to near infrared rays reaches 1.3, and the composition has a wide application prospect; the preparation method is simple and efficient, and is convenient to popularize and apply.
Detailed Description
To further illustrate the technical means and effects of the present invention, the following further describes the technical solution of the present invention with reference to the preferred embodiments of the present invention, but the present invention is not limited to the scope of the embodiments.
Example 1
(1) Adding the water phase components into a water phase pot, heating to 65 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 35 ℃ for later use; the aqueous phase comprises: water (36.23%), glycerol (6.0%), butanediol (4.0%), betaine (2.0%), sodium chloride (1.0%), methylparaben (0.2%) and disodium EDTA (0.05%);
(2) adding the oil phase components into an emulsifying pot, stirring uniformly, heating to 65 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 35 ℃ for later use;
the oil phase comprises: cyclopentadimethylsiloxane (12.0%), CI 77891 (8.0%), butanediol dicaprylate/dicaprate (5.0%), octyl methicone (3.0%), dimethicone (1.5%), lauryl PEG-9 dimethiconoethyl dimethicone (2.0%), PEG-10 dimethicone (2.5%), acrylate/dimethicone copolymer (5.0%), methyl methacrylate crosspolymer (2.0%), vinyl dimethicone/methicone silsesquioxane crosspolymer (1.0%), magnesium stearate (0.5%), aluminum hydroxide (0.01%), triethoxyoctylsilane (0.05%), cyclohexasiloxane (0.1%), CI 77491 (0.8%), CI 77499 (0.3%), and CI 77492 (0.06%);
(3) adding the water phase obtained in the step (1) into an emulsifying pot, homogenizing at 2000 rpm, and adding additives and a mixture containing 3% of Shield MLDA and 2% of additives
Figure BDA0001779950840000071
The composition of PLUS, stirred to cool to 23 ℃ to obtain the liquid foundation, the additives comprise phenoxyethanol (0.5%), ethylhexyl glycerol (0.1%), tocopheryl acetate (0.5%), bisabolol (0.5%), sodium hyaluronate (0.05%) and essence (0.05%).
Example 2
(1) Adding the water phase components into a water phase pot, heating to 60 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 30 ℃ for later use; the aqueous phase comprises: water (39.73%), glycerol (6.0%), butanediol (4.0%), betaine (2.0%), sodium chloride (1.0%), methylparaben (0.2%) and disodium EDTA (0.05%);
(2) adding the oil phase components into an emulsifying pot, stirring uniformly, heating to 60 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 30 ℃ for later use; the oil phase comprises: cyclopentadimethylsiloxane (12.0%), CI 77891 (8.0%), butanediol dicaprylate/dicaprate (5.0%), octyl methicone (3.0%), dimethicone (1.5%), lauryl PEG-9 dimethiconoethyl dimethicone (2.0%), PEG-10 dimethicone (2.5%), acrylate/dimethicone copolymer (5.0%), methyl methacrylate crosspolymer (2.0%), vinyl dimethicone/methicone silsesquioxane crosspolymer (1.0%), magnesium stearate (0.5%), aluminum hydroxide (0.01%), triethoxyoctylsilane (0.05%), cyclohexasiloxane (0.1%), CI 77491 (0.8%), CI 77499 (0.3%), and CI 77492 (0.06%);
(3) adding the water phase obtained in the step (1) into an emulsifying pot, homogenizing at the rotating speed of 2200 rpm, and adding additives and a mixture containing 1% of Shield MLDA and 0.5% of Shield MLDA
Figure BDA0001779950840000081
The composition of PLUS, stirred to cool to 20 ℃ to obtain the liquid foundation, the additives comprise phenoxyethanol (0.5%), ethylhexyl glycerol (0.1%), tocopheryl acetate (0.5%), bisabolol (0.5%), sodium hyaluronate (0.05%) and essence (0.05%).
Example 3
(1) Adding the water phase components into a water phase pot, heating to 70 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 38 ℃ for later use; the aqueous phase comprises: water (32.23%), glycerol (6.0%), butanediol (4.0%), betaine (2.0%), sodium chloride (1.0%), methylparaben (0.2%) and disodium EDTA (0.05%);
(2) adding the oil phase components into an emulsifying pot, stirring uniformly, heating to 70 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 38 ℃ for later use; the oil phase comprises: cyclopentadimethylsiloxane (12.0%), CI 77891 (8.0%), butanediol dicaprylate/dicaprate (5.0%), octyl methicone (3.0%), dimethicone (1.5%), lauryl PEG-9 dimethiconoethyl dimethicone (2.0%), PEG-10 dimethicone (2.5%), acrylate/dimethicone copolymer (5.0%), methyl methacrylate crosspolymer (2.0%), vinyl dimethicone/methicone silsesquioxane crosspolymer (1.0%), magnesium stearate (0.5%), aluminum hydroxide (0.01%), triethoxyoctylsilane (0.05%), cyclohexasiloxane (0.1%), CI 77491 (0.8%), CI 77499 (0.3%), and CI 77492 (0.06%);
(3) adding the water phase obtained in the step (1) into an emulsifying pot, homogenizing at the rotating speed of 2400 rpm, and adding additives and 5% of Shield MLDAAnd 4% of
Figure BDA0001779950840000092
The composition of PLUS, stirred to cool to 25 ℃ to obtain the liquid foundation, the additives comprise phenoxyethanol (0.5%), ethylhexyl glycerol (0.1%), tocopheryl acetate (0.5%), bisabolol (0.5%), sodium hyaluronate (0.05%) and essence (0.05%).
Example 4
(1) Adding the water phase components into a water phase pot, heating to 63 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 33 ℃ for later use; the aqueous phase comprises: water (38.23%), glycerol (6.0%), butanediol (4.0%), betaine (2.0%), sodium chloride (1.0%), methylparaben (0.2%) and disodium EDTA (0.05%);
(2) adding the oil phase components into an emulsifying pot, stirring uniformly, heating to 63 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 33 ℃ for later use; the oil phase comprises: cyclopentadimethylsiloxane (12.0%), CI 77891 (8.0%), butanediol dicaprylate/dicaprate (5.0%), octyl methicone (3.0%), dimethicone (1.5%), lauryl PEG-9 dimethiconoethyl dimethicone (2.0%), PEG-10 dimethicone (2.5%), acrylate/dimethicone copolymer (5.0%), methyl methacrylate crosspolymer (2.0%), vinyl dimethicone/methicone silsesquioxane crosspolymer (1.0%), magnesium stearate (0.5%), aluminum hydroxide (0.01%), triethoxyoctylsilane (0.05%), cyclohexasiloxane (0.1%), CI 77491 (0.8%), CI 77499 (0.3%), and CI 77492 (0.06%);
(3) adding the water phase obtained in the step (1) into an emulsifying pot, homogenizing at 2600 r/min, adding additives and a mixture containing 2% of Shield MLDA and 1% of additives
Figure BDA0001779950840000091
The composition of PLUS is stirred and cooled to 22 ℃ to obtain the foundation fluid, and the additives comprise phenoxyethanol (0.5%), ethylhexyl glycerol (0.1%), tocopheryl acetate (0.5%), bisabolol (0.5%), sodium hyaluronate (0.5%)05%) and perfume (0.05%).
Example 5
(1) Adding the water phase components into a water phase pot, heating to 68 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 36 ℃ for later use; the aqueous phase comprises: water (34.23%), glycerol (6.0%), butanediol (4.0%), betaine (2.0%), sodium chloride (1.0%), methylparaben (0.2%) and disodium EDTA (0.05%);
(2) adding the oil phase components into an emulsifying pot, stirring uniformly, heating to 68 ℃, stirring for dissolving, keeping the temperature for 30min, and cooling to 37 ℃ for later use; the oil phase comprises: cyclopentadimethylsiloxane (12.0%), CI 77891 (8.0%), butanediol dicaprylate/dicaprate (5.0%), octyl methicone (3.0%), dimethicone (1.5%), lauryl PEG-9 dimethiconoethyl dimethicone (2.0%), PEG-10 dimethicone (2.5%), acrylate/dimethicone copolymer (5.0%), methyl methacrylate crosspolymer (2.0%), vinyl dimethicone/methicone silsesquioxane crosspolymer (1.0%), magnesium stearate (0.5%), aluminum hydroxide (0.01%), triethoxyoctylsilane (0.05%), cyclohexasiloxane (0.1%), CI 77491 (0.8%), CI 77499 (0.3%), and CI 77492 (0.06%);
(3) adding the water phase obtained in the step (1) into an emulsifying pot, homogenizing at 2800 rpm, adding additives and a mixture containing 4% of Shield MLDA and 3% of additives
Figure BDA0001779950840000101
The composition of PLUS, stirred to cool to 24 ℃ to obtain the liquid foundation, the additives comprise phenoxyethanol (0.5%), ethylhexyl glycerol (0.1%), tocopheryl acetate (0.5%), bisabolol (0.5%), sodium hyaluronate (0.05%) and essence (0.05%).
Comparative example 1
The conditions were the same as in example 1 except that the mixture was filled with water without adding Shield MLDA, as compared with example 1.
Comparative example 2
Compared with example 1, except that no addition
Figure BDA0001779950840000111
PLUS, filled with water, the other conditions were the same as in example 1.
Comparative example 3
The conditions were the same as in example 1 except that the amount of Shield MLDA added was changed to 8% as compared with example 1.
Comparative example 4
Compared with example 1, except that
Figure BDA0001779950840000112
The conditions were the same as in example 1 except that the amount of PLUSs added was changed to 6%.
Comparative example 5
Compared with the example 1, the conditions are the same as the example 1 except that the temperature of the heat preservation in the step (2) is changed to 20 ℃.
Comparative example 6
The same conditions as in example 1 were used except that the incubation temperature in step (2) was 40 ℃ as compared with example 1.
Experimental detection
The compositions prepared in the examples and the comparative examples are poured into a 250mL volumetric flask, the volume is determined by deionized water, the absorption of the compositions in visible blue light (400-500nm) is measured by an ultraviolet-visible spectrophotometer, the absorption of near infrared ray IRA (700-1000nm) is measured by a near infrared spectrophotometer, and the results are shown in the following table 1;
TABLE 1
Figure BDA0001779950840000113
Figure BDA0001779950840000121
As can be seen from table 1, the foundation solutions prepared in examples 1 to 5 according to the technical scheme provided by the present invention have excellent blue light and infrared resistance, wherein the effect of example 1 is the best, the blue light absorbance reaches 2.9, the near infrared absorbance reaches 1.3, any component of the composition is absent in comparative examples 1 and 2, the ratio of the composition in comparative examples 3 and 4 exceeds the range, and the preparation parameters of comparative examples 5 and 6 exceed the range, so that the blue light and infrared resistance of the finally prepared foundation solution are both significantly reduced, which indicates that the composition provided by the present invention is not acceptable, the components are synergistic under a specific ratio, and the product obtained by the optimized preparation process has excellent blue light and infrared resistance.
Taking 11 groups of samples of foundation solutions prepared in the examples and the comparative examples, selecting 66 female testers with sensitive skin for carrying out the effect use evaluation of sensitive skin repair, and scoring 6 persons of each group of samples to obtain an average value, wherein the average value is divided into 10 points, the sensitive repair effect is the best when the average value is 10 points, and the sensitive repair effect is the worst when the average value is 9 points and 1 point. Twice daily for 7 consecutive days, the results are shown in table 2 below;
TABLE 2
Sample (I) Sensitive repair effect
Example 1 10
Example 2 8
Example 3 9
Example 4 8
Example 5 8
Comparative example 1 4
Comparative example 1 3
Comparative example 2 3
Comparative example 3 5
Comparative example 4 4
Comparative example 5 5
Comparative example 6 6
As can be seen from table 2, the foundation solutions prepared in examples 1 to 5 according to the technical scheme provided by the present invention all have good repairing effects on sensitive skin, wherein the repairing effect of example 1 is the best, the score reaches 10 parts, any component of the composition is absent in comparative examples 1 and 2, the ratio of the compositions in comparative examples 3 and 4 exceeds the range, the preparation parameters of comparative examples 5 and 6 exceed the range, and the repairing effect of the finally prepared foundation solution on sensitive skin is poor, which indicates that the composition provided by the present invention is absent, each component has synergistic effect under a specific ratio, and the optimized preparation process is assisted, so that the obtained product can effectively repair sensitive skin.
In conclusion, the active components are screened through a large number of experiments and reasonably proportioned, the two components are synergistic, so that the absorption degree of the composition on blue light and infrared rays is greatly increased, and the cosmetics prepared by the optimized process can effectively resist the blue light and the infrared rays and repair skin and relieve irritation; the method has simple process, can realize industrialized large-scale production, can bring good economic benefit for enterprises, and has wide prospect.
The applicant states that the present invention is illustrated in detail by the above examples, but the present invention is not limited to the above detailed methods, i.e. it is not meant that the present invention must rely on the above detailed methods for its implementation. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.

Claims (15)

1. A blue light-resistant and infrared-proof composition for cosmetics is characterized by comprising 2-4 parts of Shield MLDA and 2-3 parts of carnosine in parts by weight.
2. Use of a composition according to claim 1 for the preparation of a cosmetic product.
3. A cosmetic comprising the composition of claim 1.
4. The cosmetic according to claim 3, wherein the cosmetic is any one of a body lotion, a face cream, an eye cream, a sunscreen cream or a foundation.
5. The cosmetic according to claim 3, wherein the cosmetic is a foundation.
6. The cosmetic according to claim 3, wherein the composition is added in an amount of 1.5 to 9% by mass.
7. The preparation method of the foundation liquid is characterized by comprising the following steps:
(1) adding the water phase components into a water phase pot, heating, stirring, dissolving, keeping the temperature for 30 minutes, and cooling to 30-38 ℃ for later use;
(2) adding the oil phase components into an emulsifying pot, stirring uniformly, heating, stirring, dissolving, keeping the temperature for 30 minutes, and cooling to 30-38 ℃ for later use;
(3) slowly pumping the water phase obtained in the step (1) into an emulsifying pot for homogenizing and emulsifying, adding the additive and the composition as claimed in claim 1, stirring, cooling and dispersing uniformly to obtain the liquid foundation.
8. The method of claim 7, wherein the aqueous phase of step (1) comprises: any one or combination of at least two of water, glycerin, butanediol, betaine, sodium chloride, methylparaben or disodium EDTA.
9. The method according to claim 7, wherein the heating temperature in the step (1) is 60 to 70 ℃.
10. The method of claim 7, wherein the oil phase of step (2) comprises: cyclopentadimethylsiloxane, CI 77891, butanediol dicaprylate/dicaprate, octyl methicone, dimethicone, lauryl PEG-9 dimethiconoethyl dimethicone, PEG-10 dimethicone, acrylate/dimethicone copolymer, methyl methacrylate crosspolymer, vinyl dimethicone/methicone silsesquioxane crosspolymer, magnesium stearate, aluminum hydroxide, triethoxyoctylsilane, cyclohexasiloxane, CI 77491, CI 77499, or CI 77492, or any one or combination of at least two thereof.
11. The method according to claim 7, wherein the temperature of the heat-retaining in the step (2) is 60 to 70 ℃.
12. The method as claimed in claim 7, wherein the rotation speed of the homogenizing in step (3) is 2000-2800 rpm.
13. The method according to claim 7, wherein the temperature of the temperature reduction in the step (3) is 20 to 25 ℃.
14. The method of claim 7, wherein the additive comprises: any one or the combination of at least two of phenoxyethanol, ethylhexyl glycerol, tocopheryl acetate, bisabolol, sodium hyaluronate or essence.
15. The preparation method according to claim 7, which specifically comprises the steps of:
(1) adding the water phase components into a water phase pot, heating to 60-70 ℃, stirring for dissolving, keeping the temperature for 30 minutes, and cooling to 30-38 ℃ for later use;
(2) adding the oil phase components into an emulsifying pot, stirring uniformly, heating to 60-70 ℃, stirring for dissolving, keeping the temperature for 30 minutes, and cooling to 30-38 ℃ for later use;
(3) slowly pumping the water phase in the step (1) into an emulsifying pot for homogenizing and emulsifying at the rotation speed of 2000-2800 r/min, then adding the additive and the composition in the claim 1, stirring and cooling to 20-25 ℃ to obtain the liquid foundation.
CN201810987092.5A 2018-08-28 2018-08-28 Blue-light-resistant and infrared-resistant composition and application thereof Active CN108836912B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810987092.5A CN108836912B (en) 2018-08-28 2018-08-28 Blue-light-resistant and infrared-resistant composition and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810987092.5A CN108836912B (en) 2018-08-28 2018-08-28 Blue-light-resistant and infrared-resistant composition and application thereof

Publications (2)

Publication Number Publication Date
CN108836912A CN108836912A (en) 2018-11-20
CN108836912B true CN108836912B (en) 2021-05-07

Family

ID=64188295

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810987092.5A Active CN108836912B (en) 2018-08-28 2018-08-28 Blue-light-resistant and infrared-resistant composition and application thereof

Country Status (1)

Country Link
CN (1) CN108836912B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109662935A (en) * 2019-01-26 2019-04-23 广州蔻丝恩化妆品科技有限公司 Frivolous flawless foundation emulsion of one kind and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107334686A (en) * 2017-08-18 2017-11-10 广州丸美生物科技有限公司 Skin matrix, preparation method and applications and cosmetics and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107334686A (en) * 2017-08-18 2017-11-10 广州丸美生物科技有限公司 Skin matrix, preparation method and applications and cosmetics and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"BRTC MEDI STEM COLLAGEN CREAM";佚名;《http://www.cosdna.com/chs/cosmetic_b53e72142.html》;20120216;第1-3页 *
"Shield MLDA – Protecao digital 100% natural";佚名;《获取网址:https://www.biotecdermo.com.br/shield-mlda-protecao-digital-segura-100-natural/》;20170815;第1页 *

Also Published As

Publication number Publication date
CN108836912A (en) 2018-11-20

Similar Documents

Publication Publication Date Title
CN108635274B (en) Light protection composition and preparation method and application thereof
CN109939058B (en) Blue-light-proof cosmetic composition and preparation method thereof
CN106726975A (en) A kind of blue light protection component and preparation method thereof and the application in cosmetics
CN110151650A (en) A kind of Red blood streak dispelling lotion and preparation method thereof of the ingredient of composite reactive containing horse chestnut
CN110833581A (en) Anti-allergy composition, preparation method thereof, anti-allergy cosmetic and preparation method thereof
CN105106049B (en) A kind of composition and preparation method for eye-care
CN107693385A (en) A kind of sun-proof reparation cream base and preparation method thereof
CN108836912B (en) Blue-light-resistant and infrared-resistant composition and application thereof
CN106727150A (en) A kind of sun-proof skin care cosmetic composition and its application
CN101467938A (en) Chinese medicine sun cream and preparation method thereof
CN115024994A (en) High-safety sunscreen composition and preparation method and application thereof
CN106860118A (en) A kind of anti-aging face cream
CN107049883A (en) A kind of preparation method of sunflower seed extract and its application in cosmetics
JP7531249B2 (en) Sunscreen composition and method for preparing same
CN104586706B (en) A kind of Phellinus suncream and preparation method thereof
WO2018209449A1 (en) Use of naturally glycosylated polyphenols as protective agents against the effects of ultraviolet irradiation
CN110604716B (en) Light protection plant composition and preparation method and application thereof
CN101161231A (en) Ocean medicine hairdressing sun cream containing shuck powder
CN102935036A (en) Sun-screening agent free of emulsifying agent
CN115813824A (en) Plant extract with wound repair effect and preparation method and application thereof
CN108354858A (en) A kind of suncream and preparation method thereof containing marine organisms sun-screening agent
CN109939052A (en) A kind of skin care compositions of anti-skin photoage effect
CN104414867A (en) Sunscreen skin care cream containing xanthophyll
CN109925248B (en) A skin care composition containing phloretin and Panax notoginsenosides with skin photoaging resisting effect
CN109431881A (en) A kind of tibetan sheep oil of anti-chapped skin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant